Changsha, China

Qingzhi Sun

This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Sansure Biotech Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qingzhi Sun. Retrieved from https://idiyas.com/inventor/qingzhi-sun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Qingzhi Sun - Innovator in Nucleic Acid Detection

Introduction

Qingzhi Sun is a notable inventor based in Changsha, China. He is currently associated with Sansure Biotech Inc., where he focuses on advancements in nucleic acid detection methods. Despite having no granted patents to his name, his contributions to the field are significant and impactful.

Latest Patent Applications

Qingzhi Sun has been involved in several innovative patent applications. One of his latest applications is for a nucleic acid detection method. This method emphasizes rapid extraction and detection of nucleic acids, involving steps such as mixing a sample with a direct amplification preservation solution and performing ultrasonic treatment. The process is designed to be simple and efficient, significantly reducing detection time.

Another notable application is for a composition, kit, and method for detecting and typing coronaviruses. This invention is capable of identifying various coronaviruses, including the novel coronavirus 2019-nCoV and others. The method combines a fluorescent probe approach with a melting curve method, allowing for simultaneous detection and typing of multiple coronaviruses in a single tube.

Conclusion

Qingzhi Sun's work in nucleic acid detection showcases his innovative spirit and dedication to advancing medical technology. His latest patent applications reflect his commitment to improving detection methods, which can have significant implications for public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…